UroLift System by Teleflex Interventional Urology

Teleflex Incorporated is a global medical technology company that focuses on improving patient health through innovative medical devices. The UroLift System, developed by its Interventional Urology Business Unit, is designed to treat benign prostatic hyperplasia (BPH), a common condition in men that causes urinary issues due to an enlarged prostate. The UroLift System is a minimally invasive solution that provides permanent relief from prostate obstruction without the need for cutting or removing tissue. It is delivered through a transurethral outpatient procedure, placing small implants to retract obstructing prostatic lobes and open the urethra. The recently launched UroLift 2 System with Advanced Tissue Control expands treatment options for a wider range of prostate anatomies. Teleflex markets the UroLift System primarily to urologists and healthcare providers, making it available in various international markets.

• Employees15000
• Founded2004
• Annual Revenue$331100000